Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huaxia Guoyao is a prominent Chinese pharmaceutical enterprise specializing in the research, production, and distribution of Traditional Chinese Medicines (TCM) and generic pharmaceuticals. Founded in 2001 and headquartered in Beijing, the company operates a vertically integrated model that includes botanical cultivation, extraction, and the manufacturing of TCM decoction pieces. Their industrial footprint includes significant production bases in Beijing and Inner Mongolia, focused on standardized herbal processing and modern extraction technologies. In addition to manufacturing, Huaxia Guoyao maintains an extensive wholesale and retail distribution network that supplies drugs and healthcare products to hospitals and pharmacies across China. The company's portfolio primarily addresses chronic conditions in the respiratory, cardiovascular, and digestive therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huaxia Guoyao.